Seeing the Bigger Picture: Addressing Eye Drop Nonadherence

Medication adherence is a cornerstone of effective healthcare, yet eye drop nonadherence remains a pervasive issue in ophthalmology. In particular, glaucoma and dry eye disease respectively require intraocular pressure–lowering prescription and lubricant eye drops to collectively prevent worsening of their underlying pathophysiology and preserve vision. Though methods and mechanisms to improve medication adherence may seem straightforward, we contend that this chronic issue represents a multifaceted intersection of various social determinants of health and notable domains of cost, comorbidities, and patient literacy—just to name a few. Our prospective study, “Understanding Eye Drop Nonadherence for Patients with Glaucoma and Chronic Dry Eye Disease,” emerged from our shared frustration regarding the barriers that prevent patients from realizing the full benefits of their treatments. In our upcoming study, we set out to explore these challenges in depth through patient interviews and subsequent mixed-methods analysis to uncover common themes that qualitatively and quantitatively underpin nonadherence. Ultimately, our goal is to develop patient-centric strategies that address clinical shortcomings while also honoring the lived experiences of our future patients.

 

In the coming months, we will aim to conduct 50 semi-structured interviews with patients from the Rush Ophthalmology Eye Clinic. It is our hope that these conversations will help clinicians better understand the multitude of challenges patients might face when trying to physically dispense eye drops. Through our previous research and experiences, we’ve already encountered patients whose physical limitations (e.g., hand tremors, arthritis, or impaired vision) make it difficult to accurately self-administer drops. In other cases, cognitive challenges and forgetfulness, compounded by complex dosing schedules, interfere with adherence. Social determinants, including cost barriers and limited health literacy, further complicate the already tumultuous landscape of healthcare and medication access.

 

Ensuring that patients are well-informed about how their medications work, why consistency is crucial, and what long-term benefits they can expect is essential. Clear, accessible educational materials and hands-on demonstrations from healthcare providers can empower patients to take control of their treatment. When patients understand the “why” behind their regimen, they are more likely to overcome daily challenges to integrate proper eye drop use into their routines. We believe our work has the potential to transform clinical practice, and by understanding the specific challenges that patients face, we can begin to develop targeted interventions. One promising solution is the design of assistive devices tailored to the unique needs of patients with physical limitations. Imagine an eye drop dispenser with an ergonomic grip, stabilizing or gyroscopic capabilities to maintain consistent orientation, and a mechanism to ensure a consistent dose even for those with limited dexterity. Such innovations could dramatically improve adherence and patient outcomes.

 

The journey toward improved eye drop adherence is emblematic of the broader challenges in healthcare, requiring a holistic approach that considers both the technical and human elements of treatment. Our upcoming study brings to light the importance of bridging the gap between clinical recommendations and patient realities, calling for an integrated strategy that combines improved device design, better patient education, and supportive healthcare provider interactions. This is how we can ensure that every patient, regardless of physical or cognitive limitations, can fully benefit from their prescribed treatments. By involving patients in the broader conversation and valuing their insights, we can drive meaningful change that enhances both the quality and accessibility of care. Our team submission is not just an academic exercise; it is a call to action. The theme for this year’s LMSA National Journal, “Fortaleza: Crecer Más Fuerte con Cada Desafío”, resonates deeply with our anticipated work.

 

Every barrier to eye drop adherence that a patient faces represents not just a hurdle, but also an opportunity to innovate, to educate, and to build a more resilient healthcare system. By listening to our patients and understanding their challenges, we can craft solutions that make a tangible difference in their lives. Eye drop adherence is far more than a minor inconvenience or a matter of personal discipline—it is a critical factor in preventing vision loss and maintaining quality of life. Grounded in real patient experiences, our research aims to highlight the need for an interdisciplinary approach to tackle nonadherence. By developing innovative tools and fostering effective communication between patients and providers, we can create a future where every patient has the support they need to overcome challenges and preserve their sight. We hope that our work will inspire others to look at the barriers to adherence not as insurmountable obstacles, but as challenges to be overcome through collaboration, innovation, and education. Together, we can transform these challenges into opportunities for growth and resilience, embodying the spirit of true patient advocacy.